12.94
price down icon1.07%   -0.14
after-market Dopo l'orario di chiusura: 12.95 0.010 +0.08%
loading

Cogent Biosciences Inc Azioni (COGT) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Research and Development
1.31%
62.20
63.03 62.05 63.61 54.29
Costs And Expenses
0.87%
75.58
74.93 73.73 75.41 64.39
Depreciation and Amortization
2.34%
0.655
0.64 0.675 0.62 0.606
Operating Income/Loss
0.87%
-75.58
-74.93 -73.73 -75.41 -64.39
Nonoperating Income/Loss
30.34%
2.053
2.947 5.807 4.78 5.437
Income/Loss From Continuing Operations Before Tax
5.00%
-75.58
-71.99 -67.93 -75.41 -58.95
Income/Loss From Continuing Operations After Tax
2.14%
-73.53
-71.99 -67.93 -70.63 -58.95
Net Income/Loss
2.14%
-73.53
-71.99 -67.93 -70.63 -58.95
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1.02%
114.47
113.31 2.4212 110.17 99.24
Diluted Average Shares
1.02%
114.47
113.31 2.4212 110.17 99.24
Basic Earnings Per Share
1.92%
-0.53
-0.52 -0.09 -0.64 -0.59
Diluted Earnings Per Share
1.92%
-0.53
-0.52 -0.09 -0.64 -0.59
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Capitalizzazione:     |  Volume (24 ore):